Larissa Makalkina
Larissa Makalkina publishes mostly in Applied Microbiology and Biotechnology, Economics and Econometrics and Epidemiology, on topics such as Antibiotic Use and Resistance, Health Systems, Economic Evaluations, Quality of Life and Quality and Safety in Healthcare.
- World rank
- #2,428,263 of 7,710,434 ranked researchers
- Rank in Kazakhstan
- #568 of 6,463
- Works
- 21
- Citations
- 224
- Citations per work
- 10.7
What does Larissa Makalkina research?
Larissa Makalkina's work is mostly in Immunology and Microbiology (21%), Economics, Econometrics and Finance (17%), Health Professions (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else734.5%
- Life Sciences627.0%
- Social Sciences417.3%
- Health Sciences315.4%
- Health Professions27.7%
- Medicine27.7%
- Physical Sciences15.8%
- 1Applied Microbiology and Biotechnology21% of their works
- 2Economics and Econometrics17% of their works
- 3Epidemiology8% of their works
- 4Medical Laboratory Technology8% of their works
- 5Molecular Medicine6% of their works
- 6Pollution6% of their works
Research topics
- Antibiotic Use and Resistance
- Health Systems, Economic Evaluations, Quality of Life
- Quality and Safety in Healthcare
- Antibiotic Resistance in Bacteria
- Pharmaceutical and Antibiotic Environmental Impacts
- Pharmaceutical Economics and Policy
- Pneumonia and Respiratory Infections
- Pharmaceutical Quality and Counterfeiting
Which keywords describe Larissa Makalkina's research?
The keywords of their largest research topics: Antibiotic Resistance, Epidemiology, Antimicrobial Stewardship, Global Health, Cost-effectiveness Analysis, Quality of Life, Maintenance and Medical Equipment.
- Substandard Medicines
- Counterfeit Drugs
- Resistance Genes
- Generic Drugs
- Drug Development Costs
- Medical Equipment
- Quality of Life
- Global Health
- Epidemiology
- Antibiotic Resistance
- Antimicrobial Stewardship
- Cost-effectiveness Analysis
- Maintenance
- Antibiotics
- ESKAPE Pathogens
- Multidrug-Resistant Bacteria
- Community-Acquired Pneumonia
- Pneumococcal Conjugate Vaccine
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Antibiotic Resistance142 topics
- Epidemiology132 topics
- Antimicrobial Stewardship111 topic
- Global Health111 topic
- Cost-effectiveness Analysis51 topic
- Quality of Life51 topic
- Maintenance41 topic
- Medical Equipment41 topic
- Antibiotics31 topic
- Drug Development Costs31 topic
- ESKAPE Pathogens31 topic
- Generic Drugs31 topic
- Multidrug-Resistant Bacteria31 topic
- Resistance Genes31 topic
- Community-Acquired Pneumonia21 topic
- Counterfeit Drugs21 topic
- Pneumococcal Conjugate Vaccine21 topic
- Substandard Medicines21 topic
Where does Larissa Makalkina work?
Larissa Makalkina's main affiliation in the publication record is Astana Medical University, Kazakhstan.
How many publications and citations does Larissa Makalkina have?
OpenAlex counts 21 works and 224 citations for Larissa Makalkina, an h-index of 8, ranking #2,428,263 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Larissa Makalkina. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.